Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AndraTec is a private German medical device company focused on the development and distribution of minimally invasive devices for interventional cardiovascular medicine. The company was established in 2013 and markets a portfolio that includes vascular stents, PTA balloons, bifurcation stents, retrieval devices, occluders, and guide wires. Its best-known technologies include the patented Optimus stent platform and Exeter retrieval devices, with products positioned for peripheral and structural cardiovascular interventions. AndraTec states that its quality system is certified to ISO 13485/9001 and that its products are CE marked or CE pending. The business appears to operate as a commercial-stage medtech manufacturer and distributor rather than a therapeutic biotech or pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AndraTec.